Wearable sensor
Latest Biolinq Incorporated Patents:
The broken lines are for the purpose of illustrating portions of the article and form no part of the claimed design.
Claims
The ornamental design for a wearable sensor, as shown and described.
3964482 | June 22, 1976 | Gerstel et al. |
4305401 | December 15, 1981 | Reissmueller et al. |
4323996 | April 6, 1982 | Ganter |
4407295 | October 4, 1983 | Steuer et al. |
5131390 | July 21, 1992 | Sakaguchi et al. |
5279543 | January 18, 1994 | Glikfeld et al. |
5286364 | February 15, 1994 | Yacynych et al. |
5540828 | July 30, 1996 | Yacynych |
5730714 | March 24, 1998 | Guy et al. |
5766132 | June 16, 1998 | Yasukawa et al. |
6036055 | March 14, 2000 | Mogadam et al. |
6139718 | October 31, 2000 | Kurnik et al. |
6269053 | July 31, 2001 | Kawata et al. |
6284126 | September 4, 2001 | Kurnik et al. |
6413396 | July 2, 2002 | Yang et al. |
6471903 | October 29, 2002 | Sherman et al. |
D474197 | May 6, 2003 | Nguyen |
6603987 | August 5, 2003 | Whitson |
6814845 | November 9, 2004 | Wilson et al. |
6862466 | March 1, 2005 | Ackerman |
6908453 | June 21, 2005 | Fleming et al. |
7097776 | August 29, 2006 | Govinda Raju |
7132054 | November 7, 2006 | Kravitz et al. |
7262068 | August 28, 2007 | Roy et al. |
7310544 | December 18, 2007 | Brister et al. |
7343188 | March 11, 2008 | Sohrab |
7344499 | March 18, 2008 | Prausnitz et al. |
D567249 | April 22, 2008 | Gunn et al. |
7429333 | September 30, 2008 | Chiou et al. |
7456112 | November 25, 2008 | Lee |
7493232 | February 17, 2009 | Surina |
D625733 | October 19, 2010 | Anzures |
8022292 | September 20, 2011 | Arianpour et al. |
8060318 | November 15, 2011 | Vering et al. |
D651613 | January 3, 2012 | Ouilhet |
8088321 | January 3, 2012 | Ferguson et al. |
8094009 | January 10, 2012 | Allen et al. |
8125331 | February 28, 2012 | Allen et al. |
8130095 | March 6, 2012 | Allen et al. |
8280475 | October 2, 2012 | Brister et al. |
8284046 | October 9, 2012 | Allen et al. |
8574165 | November 5, 2013 | Marsh |
D699251 | February 11, 2014 | Rao et al. |
D701964 | April 1, 2014 | Yoneta et al. |
8750955 | June 10, 2014 | Brister et al. |
8798799 | August 5, 2014 | Deo et al. |
8909543 | December 9, 2014 | Tropper et al. |
D722697 | February 17, 2015 | Moon et al. |
9041730 | May 26, 2015 | Johnson et al. |
9055901 | June 16, 2015 | Brister et al. |
9107623 | August 18, 2015 | Brauker et al. |
D744529 | December 1, 2015 | Guzmán et al. |
D745046 | December 8, 2015 | Shin et al. |
D750786 | March 1, 2016 | Davies et al. |
D757000 | May 24, 2016 | Lagomarsino et al. |
D760277 | June 28, 2016 | Park |
D763894 | August 16, 2016 | Lamparelli |
D771824 | November 15, 2016 | Minoli |
D773529 | December 6, 2016 | Cabrera, Jr. et al. |
D776285 | January 10, 2017 | Dinger |
9551698 | January 24, 2017 | Huys et al. |
D778952 | February 14, 2017 | Kim et al. |
D789391 | June 13, 2017 | Cabrera, Jr. et al. |
D794801 | August 15, 2017 | Newhouse et al. |
9717843 | August 1, 2017 | Grucela et al. |
9737247 | August 22, 2017 | Wang et al. |
9743870 | August 29, 2017 | Wang et al. |
D803250 | November 21, 2017 | Lee et al. |
D806706 | January 2, 2018 | Kim et al. |
D810952 | February 20, 2018 | Hsu |
D813877 | March 27, 2018 | Hough et al. |
D815289 | April 10, 2018 | Evers et al. |
D816229 | April 24, 2018 | Frick et al. |
9933387 | April 3, 2018 | McCanna et al. |
D820988 | June 19, 2018 | Pushpala et al. |
D821571 | June 26, 2018 | Stonecipher et al. |
10004435 | June 26, 2018 | Larvenz et al. |
10029043 | July 24, 2018 | Grucela et al. |
10092207 | October 9, 2018 | Windmiller |
D832870 | November 6, 2018 | Hu |
D833023 | November 6, 2018 | Maletic |
10136846 | November 27, 2018 | Wang et al. |
D842996 | March 12, 2019 | Frick et al. |
D845289 | April 9, 2019 | Chuang et al. |
10251565 | April 9, 2019 | Chan et al. |
D850626 | June 4, 2019 | Gardner et al. |
10321859 | June 18, 2019 | Wynbrandt et al. |
D853382 | July 9, 2019 | Haigh |
10362973 | July 30, 2019 | Hernandez-Rosas et al. |
D864985 | October 29, 2019 | Kim et al. |
D864993 | October 29, 2019 | Kim et al. |
D867911 | November 26, 2019 | Alabdin |
D870291 | December 17, 2019 | Barry et al. |
10492708 | December 3, 2019 | Windmiller |
D873294 | January 21, 2020 | Anzures et al. |
D875106 | February 11, 2020 | Winton et al. |
D875254 | February 11, 2020 | Cooke et al. |
D882432 | April 28, 2020 | Yee et al. |
D888731 | June 30, 2020 | Momchilov et al. |
10765369 | September 8, 2020 | Antonio et al. |
D898924 | October 13, 2020 | Hinds et al. |
D903877 | December 1, 2020 | Pace et al. |
11039767 | June 22, 2021 | Hayter |
11045142 | June 29, 2021 | Windmiller et al. |
D928150 | August 17, 2021 | Maruyama et al. |
11087868 | August 10, 2021 | Budiman |
11102306 | August 24, 2021 | Mensinger et al. |
D929990 | September 7, 2021 | Maruyama et al. |
D931467 | September 21, 2021 | Golda et al. |
11141116 | October 12, 2021 | Cabrera, Jr. et al. |
11150145 | October 19, 2021 | Nekoomaram et al. |
11154253 | October 26, 2021 | Cabrera, Jr. et al. |
11182332 | November 23, 2021 | Anderson et al. |
11197626 | December 14, 2021 | Koehler et al. |
11205511 | December 21, 2021 | Hayter et al. |
11207025 | December 28, 2021 | Trapero et al. |
11272890 | March 15, 2022 | McGarraugh |
11305906 | April 19, 2022 | Grucela et al. |
D951972 | May 17, 2022 | Vincent et al. |
11317867 | May 3, 2022 | Garai et al. |
D954744 | June 14, 2022 | Feitosa et al. |
11357430 | June 14, 2022 | Pushpala et al. |
11373347 | June 28, 2022 | Kamath et al. |
D957438 | July 12, 2022 | Hayter et al. |
D958184 | July 19, 2022 | Page |
D958817 | July 26, 2022 | Mensinger et al. |
11389088 | July 19, 2022 | Desborough et al. |
D960895 | August 16, 2022 | Mensinger |
D960913 | August 16, 2022 | Kiikkala et al. |
D962446 | August 30, 2022 | Bernstein et al. |
11406331 | August 9, 2022 | Budiman |
11406818 | August 9, 2022 | Windmiller |
11437141 | September 6, 2022 | Mensinger et al. |
11446108 | September 20, 2022 | Larson et al. |
D967128 | October 18, 2022 | Kumar et al. |
D967136 | October 18, 2022 | Kumar et al. |
11464459 | October 11, 2022 | Sjolund et al. |
11475988 | October 18, 2022 | Burkart et al. |
11478194 | October 25, 2022 | Windmiller et al. |
11497422 | November 15, 2022 | Koehler et al. |
11507530 | November 22, 2022 | Anderson et al. |
11517222 | December 6, 2022 | Pushpala et al. |
11534089 | December 27, 2022 | Taub et al. |
D977116 | January 31, 2023 | Gennaco et al. |
11547799 | January 10, 2023 | Zhong et al. |
D978178 | February 14, 2023 | Lamb et al. |
D978357 | February 14, 2023 | Zysk et al. |
11576600 | February 14, 2023 | Lee et al. |
11654270 | May 23, 2023 | Mansfield, III et al. |
11660392 | May 30, 2023 | Kamen et al. |
D988160 | June 6, 2023 | Morelock |
11672965 | June 13, 2023 | Mansfield et al. |
D996999 | August 29, 2023 | Morelock |
D1004105 | November 7, 2023 | Zysk et al. |
D1006265 | November 28, 2023 | Quitter et al. |
D1006266 | November 28, 2023 | Quitter et al. |
D1010133 | January 2, 2024 | Yee et al. |
D1012292 | January 23, 2024 | Armstrong et al. |
D1012744 | January 30, 2024 | Morelock |
11857344 | January 2, 2024 | Windmiller et al. |
11872055 | January 16, 2024 | Tangney et al. |
D1013544 | February 6, 2024 | Morelock |
11904127 | February 20, 2024 | Mansfield et al. |
11963796 | April 23, 2024 | Windmiller et al. |
11986614 | May 21, 2024 | Mansfield et al. |
12011294 | June 18, 2024 | Campbell et al. |
D1033641 | July 2, 2024 | Morelock |
D1035004 | July 9, 2024 | Morelock |
D1035670 | July 16, 2024 | Vanderhill et al. |
D1038794 | August 13, 2024 | Morelock |
D1040171 | August 27, 2024 | Chen et al. |
12070313 | August 27, 2024 | Fuchs et al. |
12109032 | October 8, 2024 | Windmiller et al. |
D1051745 | November 19, 2024 | Morelock |
D1057153 | January 7, 2025 | Morelock |
20030225360 | December 4, 2003 | Eppstein et al. |
20060015061 | January 19, 2006 | Kuo et al. |
20070170054 | July 26, 2007 | Wilsey |
20070213044 | September 13, 2007 | Steingart et al. |
20090088652 | April 2, 2009 | Tremblay |
20090143761 | June 4, 2009 | Cantor et al. |
20090259118 | October 15, 2009 | Feldman et al. |
20100056873 | March 4, 2010 | Allen et al. |
20100286803 | November 11, 2010 | Tillotson et al. |
20120323097 | December 20, 2012 | Chowdhury |
20130065257 | March 14, 2013 | Wang et al. |
20130144131 | June 6, 2013 | Wang et al. |
20140259652 | September 18, 2014 | Pushpala et al. |
20140275897 | September 18, 2014 | Pushpala et al. |
20140336487 | November 13, 2014 | Wang et al. |
20150335272 | November 26, 2015 | Natale et al. |
20150351689 | December 10, 2015 | Adams et al. |
20170003766 | January 5, 2017 | Budiman |
20170055851 | March 2, 2017 | Al-Ali |
20170215774 | August 3, 2017 | Koehler et al. |
20170290532 | October 12, 2017 | Antonio et al. |
20180042559 | February 15, 2018 | Cabrera, Jr. et al. |
20180116572 | May 3, 2018 | Simpson et al. |
20180249937 | September 6, 2018 | Wiese et al. |
20180295897 | October 18, 2018 | Donohoe et al. |
20190095602 | March 28, 2019 | Setlak et al. |
20190125223 | May 2, 2019 | Wang et al. |
20190133638 | May 9, 2019 | Ii et al. |
20190167167 | June 6, 2019 | Mitchell et al. |
20190246914 | August 15, 2019 | Constantin et al. |
20190246973 | August 15, 2019 | Constantin et al. |
20190274603 | September 12, 2019 | Ringemann |
20190307376 | October 10, 2019 | Hernandez-Rosas et al. |
20190309433 | October 10, 2019 | Sattayasamitsathit et al. |
20200085341 | March 19, 2020 | Windmiller |
20200101286 | April 2, 2020 | Windmiller et al. |
20200146598 | May 14, 2020 | Mayou et al. |
20200214566 | July 9, 2020 | Allen et al. |
20200245914 | August 6, 2020 | Bhavaraju et al. |
20200254240 | August 13, 2020 | Windmiller et al. |
20200275870 | September 3, 2020 | Bhavaraju et al. |
20200297997 | September 24, 2020 | Windmiller et al. |
20200337615 | October 29, 2020 | Larvenz et al. |
20210113132 | April 22, 2021 | Bhagat et al. |
20210161436 | June 3, 2021 | Troncelliti et al. |
20210169384 | June 10, 2021 | Taub et al. |
20210187286 | June 24, 2021 | Windmiller et al. |
20210196162 | July 1, 2021 | Halac et al. |
20210236057 | August 5, 2021 | Pushpala et al. |
20210282672 | September 16, 2021 | Kumar et al. |
20210321914 | October 21, 2021 | Brister et al. |
20210335499 | October 28, 2021 | Simpson et al. |
20210345894 | November 11, 2021 | Maceachern et al. |
20210361199 | November 25, 2021 | Kumar |
20210378601 | December 9, 2021 | Kumar et al. |
20210393201 | December 23, 2021 | Morelock et al. |
20220000399 | January 6, 2022 | Hayter et al. |
20220000432 | January 6, 2022 | Cabrera, Jr. et al. |
20220031209 | February 3, 2022 | Windmiller et al. |
20220031244 | February 3, 2022 | Windmiller et al. |
20220057868 | February 24, 2022 | Budiman |
20220080678 | March 17, 2022 | Cole et al. |
20220087610 | March 24, 2022 | Pushpala et al. |
20220095930 | March 31, 2022 | Li et al. |
20220101995 | March 31, 2022 | Johnson et al. |
20220142524 | May 12, 2022 | Harper et al. |
20220142589 | May 12, 2022 | Lee |
20220175278 | June 9, 2022 | Campbell et al. |
20220194644 | June 23, 2022 | Grucela et al. |
20220202319 | June 30, 2022 | Crawford et al. |
20220202320 | June 30, 2022 | Diener et al. |
20220216735 | July 7, 2022 | Yan et al. |
20220265224 | August 25, 2022 | Hauptman et al. |
20220283042 | September 8, 2022 | Nekoomaram et al. |
20220292746 | September 15, 2022 | Kamath et al. |
20220336100 | October 20, 2022 | Chiu et al. |
20220361825 | November 17, 2022 | Kang |
20220370011 | November 24, 2022 | Windmiller et al. |
20220392643 | December 8, 2022 | Mensinger et al. |
20230005588 | January 5, 2023 | Sokolovskyy et al. |
20230074798 | March 9, 2023 | Tangney et al. |
20230094419 | March 30, 2023 | Mansfield, III et al. |
20230099617 | March 30, 2023 | Mansfield, III et al. |
20230137258 | May 4, 2023 | Windmiller |
20230190147 | June 22, 2023 | Campbell et al. |
20230256220 | August 17, 2023 | Mansfield, III |
20230301552 | September 28, 2023 | Mallires et al. |
20230310823 | October 5, 2023 | Mansfield, III |
20230414102 | December 28, 2023 | Allen et al. |
20240008777 | January 11, 2024 | Fuchs |
20240081740 | March 14, 2024 | Windmiller et al. |
20240164719 | May 23, 2024 | Campbell et al. |
20240252115 | August 1, 2024 | Tangney et al. |
20240315614 | September 26, 2024 | Campbell et al. |
20240341636 | October 17, 2024 | Yang et al. |
20240366125 | November 7, 2024 | Alonso-Soski et al. |
20240382157 | November 21, 2024 | Windmiller et al. |
20240408366 | December 12, 2024 | Mansfield et al. |
20240423526 | December 26, 2024 | Windmiller et al. |
20250000395 | January 2, 2025 | Brister et al. |
20250049397 | February 13, 2025 | Campbell et al. |
717520 | December 2021 | CH |
305781317 | May 2020 | CN |
306169676 | November 2020 | CN |
306260908 | January 2021 | CN |
306893408 | October 2021 | CN |
307293994 | April 2022 | CN |
307384488 | June 2022 | CN |
307672333 | November 2022 | CN |
308050427 | May 2023 | CN |
001371280-0001 | June 2013 | EM |
3871602 | September 2021 | EP |
3042872 | December 2020 | FR |
06192168 | February 2022 | GB |
1721016 | July 2022 | JP |
2013502603 | November 2014 | KR |
WO-2009034313 | March 2009 | WO |
WO-2009034313 | March 2009 | WO |
WO-2009064164 | May 2009 | WO |
WO-2009064164 | May 2009 | WO |
WO-2010107913 | September 2010 | WO |
WO-2010120364 | October 2010 | WO |
WO-2010120364 | October 2010 | WO |
WO-2012020332 | February 2012 | WO |
WO-2012020332 | February 2012 | WO |
WO-2013058879 | April 2013 | WO |
WO-2013058879 | April 2013 | WO |
WO-2020073060 | April 2020 | WO |
WO-D214300002 | May 2021 | WO |
WO-2021148596 | July 2021 | WO |
WO-2022044017 | March 2022 | WO |
WO-2022031792 | April 2022 | WO |
WO-2022044018 | April 2022 | WO |
WO-2022266443 | December 2022 | WO |
WO-2023055755 | April 2023 | WO |
WO-2023064877 | April 2023 | WO |
WO-2023133468 | July 2023 | WO |
WO-2023229662 | November 2023 | WO |
WO-2024010827 | January 2024 | WO |
WO-2024163950 | August 2024 | WO |
WO-2024238798 | November 2024 | WO |
- Abbot press release (2020). “New late-breaking data show use of Abbott's Freestyle® Libre System significantly reduces HBA1C levels in people with type 2 diabetes using insulin or not,” 3 pages.
- Al Hayek et al., “Patient Satisfaction and Clinical Efficacy of Novel Blood Glucose Meters Featuring Color Range Indicators in Patients With Type 2 Diabetes: A Prospective Study” Cureus Oct. 27, 2020; 12(10):e11195. 8 pages. doi:10.7759/cureus.11195.
- Allen et al., “Continuous glucose monitoring counseling improves physical activity behaviors of individuals with type 2 diabetes: A randomized clinical trial” Diabetes Res Clin Pract. Jun. 2008 80(3): 371-379. doi:10.1016/j.diabres.2008.01.006.
- American Diabetes Association® Press Release (2020). “American Diabetes Association® Applauds policymakers' Focus on Addressing High Costs of Insulin for Seven Million Americans,” 4 pages.
- Bantle, J.P. et al. (1997). “Glucose measurement in patients with diabetes mellitus with dermal interstitial fluid,” J. Lab. Clin. Med. 130:436-441.
- Barrett et al., “Risk for Newly Diagnosed Diabetes 30 Days After SARS-CoV-2 Infection Among Persons Aged 18 Years—United States, Mar. 1, 2020-Jun. 28, 2021” MMWR Morb Mortal Wkly Rep. Jan. 14, 2022; 71(2):59-65. doi:10.15585/mmwr.mm7102e2.
- Beckles, G.L. et al. (2016). “Disparities in the prevalence of diagnosed diabetes—United States, 1999-2002 and 2011-2014,” MMWR 65:1265-1269.
- Biolinq, Inc. (2019). The Intelligent Continuous Glucose Monitoring System, 5 total pages.
- Cao, J. et al. (2017). “Validation of capillary blood analysis and capillary testing mode on the epoc Point of Care system,” Pract. Lab. Med. 9:24-27.
- Castle, J.R. et al. (2012). “The accuracy benefit of multiple amperometric glucose sensors in people with type 1 diabetes,” Diabetes Care 35:706-710.
- Centers for Disease Control, “National Diabetes Statistics Report 2020 Estimates of Diabetes and Its Burden in the United States” (2020) 32 pages.
- Dexcom (2020). Analyst Day Presentation, 19 total pages.
- Dexcom (2020). Analyst Day Presentation, 27 total pages.
- Diabetes Care (2021). “7. Diabetes Technology: Standards of Medical Care in Diabetes—2021,” Diabetes Care 44(Supplement 1):S85-S99.
- Dunkin et al., “Scarring occurs at a critical depth of skin injury: precise measurement in a graduated dermal scratch in human volunteers” Plast Reconstr Surg. May 2007; 119(6):1722-1732. doi: 10.1097/01.prs.0000258829.07399.f0.
- Ehrhardt et al., “Behavior Modification in Prediabetes and Diabetes: Potential Use of Real-Time Continuous Glucose Monitoring” Journal of Diabetes Science and Technology Mar. 2019; 13(2):271-275.
- Ehrhardt et al., “Continuous Glucose Monitoring as a Behavior Modification Tool” Clin Diabetes. Apr. 2020; 38(2):126-131. doi: 10.2337/cd19-0037.
- Ehrhardt et al., “The Effect of Real-Time Continuous Glucose Monitoring on Glycemic Control in Patients with Type 2 Diabetes Mellitus” Journal of Diabetes Science and Technology May 2011; 5(3):668-675.
- Fang, M. et al. (2021). “Trends in Diabetes Treatment and Control in U.S. Adults, 1999-2018,” N. Engl. Med. 384:2219-2228.
- Fonda et al., “The Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (RT-CGM) in Type 2 Diabetes” Journal of Diabetes Science and Technology (2016) 10(4):898-904.
- French, D.P. et al. (2008). “Original Article: Psychological Care Self-monitoring of blood glucose changed non-insulin-treated Type 2 diabetes patients' beliefs about diabetes and self-monitoring in a randomized trial,” Diav. Med. 25:1218-1228.
- Grady, M. et al. (2017). “Examining the Impact of a Novel Blood Glucose Monitor with Color Range Indicator on Decision-Making in Patients With Type 1 and Type 2 Diabetes and its Association With Patient Numeracy Level,” JMIR Diabetes 2:e24. 11 pages.
- Grady, M. et al. (2018). “Use of Blood Glucose Meters Featuring Color Range Indicators Improves Glycemic Control in Patients with Diabetes in Comparison to Blood Glucose Meters Without Color (Accents Study),” J. Diab. Sci. Tech. 12:1211-1219.
- Groenendaal, W. et al. (2008). “Modeling Glucose and Water Dynamics in Human Skin,” Diab. Tech. Therap. 10:283-293.
- Han et al., “The End of the Road for the YSI 2300 Analyzer: Where Do We Go Now?” Journal of Diabetes Science and Technology (2020) 14(3):595-600.
- Han et al., “The YSI 2300 Analyzer Replacement Meeting Report” Journal of Diabetes Science and Technology (2020) 14(3):679-686.
- Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2008). “Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes,” N. Engl. Med. 359:1464-1476.
- Karter, A.J. et al. (2021). “Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes,” JAMA 325:2273-2284.
- Martens, T. et al. (2021). “Effect of Continuous Glucose Monitoring on Glycemic Control in Patients with Type 2 Diabetes Treated with Basal Insulin A Randomized Clinical Trial,” JAMA 325:2262-2272.
- McClatchey, P.M. et al. (2019). “Fibrotic Encapsulation Is the Dominant Source of Continuous Glucose Monitor Delays,” Diabetes 68:1892-1901.
- Neerken, S. et al. (2004). “Characterization of age-related effects in human skin: A comparative study that applies confocal laser scanning microscopy and optical coherence tomography,” J. Biomed. Optics 9:274-281.
- Non-Final Office Action mailed on Nov. 14, 2019, for U.S. Appl. No. 29/650,794, filed Jun. 8, 2018, 10 pages.
- Notice of Allowance mailed on Dec. 18, 2019, for U.S. Appl. No. 29/650,794, filed Jun. 8, 2018, 7 pages.
- Notice of Allowance mailed on Sep. 29, 2022, for U.S. Appl. No. 29/774,399, filed Mar. 16, 2021, 7 pages.
- Notice of Allowance mailed on Jan. 25, 2023, for U.S. Appl. No. 29/774,399, filed Mar. 16, 2021, 11 pages.
- Notice of Allowance mailed on Mar. 1, 2023, for U.S. Appl. No. 29/815,797, filed Nov. 16, 2021, 10 pages.
- Notice of Allowance mailed on May 17, 2023, for U.S. Appl. No. 29/836,984, filed Apr. 29, 2022, 7 pages.
- Notice of Allowance mailed on May 31, 2023, for U.S. Appl. No. 29/838,870, filed May 16, 2022, 7 pages.
- Notice of Allowance mailed on Jun. 14, 2023, for U.S. Appl. No. 29/815,797, filed Nov. 16, 2021, 9 pages.
- Polonsky, W.H. et al. (2011). “A survey of blood glucose monitoring in patients with type 2 diabetes: Are recommendations from health care professionals being followed?” Curr. Med. Res. & Opinion 27:31-37.
- Rigla, M. et al. (2018). “Human Subcutaneous Tissue Response to Glucose Sensors: Macrophages Accumulation Impact on Sensor Accuracy,” Diabetes Technology & Therapeutics 20:296-302.
- Sharifi et al., “Redundancy in Glucose Sensing: Enhanced Accuracy and Reliability of an Electrochemical Redundant Sensor for Continuous Glucose Monitoring” Journal of Diabetes Science and Technology (2016) 10(3):669-678.
- Sheikh, Z. et al. (2015). “Macrophages, Foreign Body Giant Cells and Their Response to Implantable Biomaterials,” Materials 8:5671-5701.
- Shi, T. et al. (2016). “Modeling and Measurement of Correlation between Blood and Interstitial Glucose Changes,” J. Diab. Res. Volume 2016, 9 pages.
- Turner et al., “Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)” The Lancet Sep. 1998; 352(9131):837-853.
- Vigersky et al., “Short- and Long-Term Effects of Real-Time Continuous Glucose Monitoring in Patients with Type 2 Diabetes” Diabetes Care Jan. 2012; 35:32-38.
- Wolicki et al., “Epidemiology and Prevention of Vaccine-Preventable Diseases: Chapter 6: Vaccine Administration” Centers for Disease Control and Prevention (2021) 17 pages.
- World Health Organization, “Diabetes”, Sep. 16, 2022, 5 pages.
- Young et al., “Glucose Self-monitoring in Non-Insulin-Treated Patients With Type 2 Diabetes in Primary Care Settings: A Randomized Trial” JAMA Intern Med. Jul. 2017; 177(7):920-929.
- Notice of Allowance mailed on Nov. 22, 2023, for U.S. Appl. No. 29/838,870, filed May 16, 2022, 7 pages.
- Notice of Allowance mailed on Nov. 29, 2023, for U.S. Appl. No. 29/836,984, filed Apr. 29, 2022, 7 pages.
- Abbott, Abbott's Freestyle® Libre 3 System Receives CE Mark, Published on: Sep. 28, 2020, PRNewswire.com, Retrieved from Internet: https://www.prnewswire.com/news-releases/abbotts-freestyle-libre-3-system-receives-ce-mark--features-worlds-smallest-thinnest-sensor-with-best-in-class-performance-at-the-same-low-cost-for -people-with-diabetes-301138719.html, 2 pages.
- AiDEX, www.appadvice.com, retrieved online Sep. 4, 2024, posted online Nov. 9, 2022 URL:https://appadvice.com/app/wellion-aidex-sensor-mmol-I/6444144767. 1 page.
- American Diabetes Association, “Diabetes and Emotional Health: A Practical Guide for Health Professionals Supporting Adults with Type 1 and Type 2 Diabetes” U.S. Edition (2021), 214 pages.
- American Diabetes Association Professional Practice Committee, “6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes-2024” Diabetes Care Jan. 1, 2024; 47(Suppl 1):S111-S125.
- American Diabetes Association Professional Practice Committee, “7. Diabetes Technology: Standards of Medical Care in Diabetes—2022” Diabetes Care Jan. 1, 2022; 45(Suppl 1):S97-S112.
- Battelino et al., “Continuous glucose monitoring and metrics for clinical trials: an international consensus statement” Lancet Diabetes Endocrinol (2023) 11:42-57.
- Biolinq, “Biolinq Announces Results from First-in-Man Clinical Studies Showing Feasibility of a Novel, Minimally Invasive Approach to Continuous Glucose Monitoring in the Dermis” Published on: Jun. 15, 2020, PRNewswire.com, Retrieved from Internet https://www.prnewswire.com/news-releases/biolinq-announces-results-from-first-in-man-clinical-studies-showing-feasibility-of-a-novel-minimally-invasive-approach-to-continuous-glucose-monitoring-in-the-dermis-301076992. html, 3 pages.
- Blue Circle, www.instagram.com, By bluecirclediabetesfoundation, retrieved Sep. 4, 2024, posted online Jan. 12, 2020 URL:https://www.instagram.com/p/B7OINIHBIAD/?utm_source=ig_embed&utm_campaign=loading. 1 page.
- Centers for Disease Control, “National Diabetes Statistics Report” May 2024, 16 pages.
- Clutter et al., “Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man” J Clin Invest. (1980) 66(1):94-101.
- Czupryniak et al., “Ambulatory Glucose Profile (AGP) Report in Daily Care of Patients with Diabetes: Practical Tips and Recommendations” Diabetes Ther (2022) 13:811-821.
- Delve, Dexcom G6, Published in: 2019, Designdirectory.com, Retrieved from Internet: https://www.designdirectory.com/delve/Dexcom-G6?AspxAutoDetectCookieSupport=1 (Year: 2019), 3 pages.
- Dexcom, www.diabetesstrong.com, By Christel Oerum, MS, retrieved online Sep. 4, 2024, posted online Apr. 20, 2020 URL:http://web.archive.org/web/20200420123603/https://diabetesstrong.com/dexcom-cgm-trend-arrows/. 1 page.
- Diabetes Control and Complications Trial Research Group, “The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus” N Engl J Med Sep. 30, 1993; 329(14):977-986.
- Diabetes.co.uk, “FDA approves new CGM the Abbott FreeStyle Libre Pro System” Published on: Sep. 29, 2016, diabetes.co.uk, Retrieved from Internet: https://www.diabetes.co.uk/news/2016/sep/fda-approves-new-cgm-the-abbott-freestyle-libre-pro-system-90611033.html (Year: 2016), 2 pages.
- Donnelly et al., “Microneedle Arrays Allow Lower Microbial Penetration Than Hypodermic Needles In Vitro” Pharmaceutical Research (2009) 26(11):2513-2522.
- Elsayed et al., “2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes—2023” Diabetes Care Jan. 1, 2023; 46(Suppl 1):S19-S40.
- Fayfman et al., “Management of Hyperglycemic Crises: Diabetic ketoacidosis and hyperglycemic hyperosmolar state” Med Clin North Am. May 2017; 101(3):587-606.
- Garg et al., “Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes”, Published on: May 31, 2022, Diabetes Technology & Therapeutics, Retrieved from Internet: https://www.liebertpub.com/doi/10.1089/dia.2022.0011 (Year: 2022), 2 pages.
- Ghimire et al., “Ketoacidosis” StatPearls Publishing, Jan. 2024, NCBI Bookshelf, 8 pages.
- Heinemann, “Interferences With CGM Systems: Practical Relevance?” Journal of Diabetes Science and Technology (2022) vol. 16(2) 271-274.
- Henry et al. “Microfabricated microneedles: a novel approach to transdermal drug delivery.” Journal of pharmaceutical sciences. Aug. 1, 1998;87(8):922-925.
- Idrus, “Medtronic integrates CGM, Fitbit data into mobile app” Published on: Dec. 19, 2016, Fierce Biotech.com, Retrieved from Internet : https://www.fiercebiotech.com/medical-devices/medtronic-integrates-cgm-fitbit-data-into-mobile-app (Year: 2016), 1 page.
- Jina, A et al. (2014). “Design, development, and evaluation of a novel microneedle array-based continuous glucose monitor,” J. Diabetes Sci. Technol. 8:483-487.
- Maahs et al., “Effect of Acetaminophen on CGM Glucose in an Outpatient Setting” Diabetes Care (2015) 38:e158-e159.
- Mendes-Soares et al., “Assessment of a Personalized Approach to Predicting Postprandial Glycemic Responses to Food Among Individuals Without Diabetes” JAMA Network Open Feb. 1, 2019; 2(2):e188102. 13 pages.
- Miller et al., “Hypoglycemia in patients with type 2 diabetes mellitus” Arch Intern Med Jul. 9, 2001; 161(13):1653-1659.
- Newton et al., “Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus: clinical and biochemical differences” Arch Intern Med Sep. 27, 2004; 164(17):1925-1931.
- Nguyen et al., “Human studies with microneedles for evaluation of their efficacy and safety” Expert Opinion on Drug Delivery (2018) 15:3, 235-245.
- Non-Final Office Action for U.S. Appl. No. 29/885,802 mailed Sep. 19, 2024, 10 pages.
- Non-Final Office Action for U.S. Appl. No. 29/890,886 dated Mar. 28, 2024, 11 pages.
- Notice of Allowance for U.S. Appl. No. 29/871,863 dated Feb. 26, 2024, 10 pages.
- Notice of Allowance for U.S. Appl. No. 29/885,801 mailed Nov. 22, 2024, 10 pages.
- Notice of Allowance for U.S. Appl. No. 29/890,886 mailed Jul. 15, 2024, 7 pages.
- Notice of Allowance for U.S. Appl. No. 29/919,992 dated Mar. 28, 2024, 8 pages.
- Ohashi et al., “Analgesic Effect of Acetaminophen: A Review of Known and Novel Mechanisms of Action” Front Pharmacol. Nov. 30, 2020;11:580289, 6 pages.
- Prausnitz, “Engineering Microneedle Patches for Vaccination and Drug Delivery to Skin” Annu. Rev. Chem. Biomol. Eng. (2017) 8:177-200.
- PRNewswire L'Oreal Unveils Prototype First-Ever Wearable Microfluidic Sensor, posted Jan. 6, 2019[online], [retrieved Jul. 2, 2024]. Retrieved from internet,https://www.prnewswire.com/news-releases/loreal-unveils-prototype-of-first-ever-wearable-microfluidic-sensor-to-measure-skin-ph-levels-300773342.html (Year: 2019), 11 pages.
- Roche Diabetes Care, Roche Diabetes Carey Senseonics anuncian un acuerdo de distribuci6n para el sistema Eversense® CGM, Published on: May 26, 2016, PRNewswire.com, Retrieved from Internet: https://www.prnewswire.com/news-releases/roche-diabetes-care-y-senseonics-anuncian-un-acuerdo-de-distribucion-para-el-sistema-eversense-cgm-580978821.html, 1 page.
- Round Navigation, www.pngtree.com, By 588ku, retrieved Sep. 4, 2024, posted online Jun. 18, 2018 URL:https://pngtree.com/freepng/round-navigation-icon_4752591.html. 1 page.
- Samant et al., “Mechanisms of sampling interstitial fluid from skin using a microneedle patch,” Proc. Natl Acad. Sci. U.S.A. (2018) 115(8):4583-4588.
- Segel et al., “Hypoglycemia-associated autonomic failure in advanced type 2 diabetes” Diabetes Mar. 2002; 51(3):724-733.
- Shivers et al., “Turn it off !: diabetes device alarm fatigue considerations for the present and the future” J Diabetes Sci Technol May 1, 2013; 7(3):789-794.
- Springer Link Microneedle—Based Sensor Systems for Real-Time Continuous Transdermal Monitoring of Analytes in Body Fluids, posted May 11, 2019 [online], [retrieved Jul. 2, 2024]. Retrieved from internet, https://link.springer.com/chapter/10.1007/978-3-030-17971-7_26 (Year: 2019), 23 pages.
- Tanenbaum et al., “Diabetes Device Use in Adults With Type 1 Diabetes: Barriers to Uptake and Potential Intervention Targets” Diabetes Care Feb. 2017 40(2):181-187.
- UK Prospective Diabetes Study (UKPDS) Group, “Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)” Lancet Sep. 12, 1998; 352(9131):837-853.
- Vicente-Perez et al., “Repeat application of microneedles does not alter skin appearance or barrier function and causes no measurable disturbance of serum biomarkers of infection, inflammation or immunity in mice in vivo” European Journal of Pharmaceutics and Biopharmaceutics (2017) 117:400-407.
- WaveForm Technologies Inc., “WaveForm Technologies Inc. Awarded CE Mark Approval for Their Continuous Glucose Monitoring System” Published on: Nov. 5, 2019, PRNewswire.com, Retrieved from Internet https://www.prnewswire.com/news-releases/waveform-technologies-inc-awarded-ce-mark-approval-for-their-continuous-glucose-monitoring-system-300952002. html, 1 page.
- Windmiller, J.R et al. (2011). “Microneedle array-based carbon paste amperometric sensors and biosensors,” Analyst 136:1846-1851.
- Yue et al., “Evaluation of a 12-Hour Sustained-Release Acetaminophen (Paracetamol) Formulation: A Randomized, 3-Way Crossover Pharmacokinetic and Safety Study in Healthy Volunteers” Clinical Pharmacology in Drug Development (2018) 7(1) 95-101.
Type: Grant
Filed: May 16, 2023
Date of Patent: Jul 15, 2025
Assignee: Biolinq Incorporated (San Diego, CA)
Inventor: David Michael Morelock (Escondido, CA)
Primary Examiner: Antoine Duval Davis
Application Number: 29/876,134